From: Single-center evaluation of prognostic factors for thymoma treated by surgery: a retrospective study
Variables | n = 60 | Five-year survival (%) | P |
---|---|---|---|
Sex | |||
Male | 30 | 93 | 0.225 |
Female | 30 | 100 | |
Age (years) | |||
< 50 | 15 | 100 | 0.376 |
≧50 | 45 | 95 | |
Masaoka stage, n (%) | |||
I-II | 51 | 100 | < 0.001 |
III-IV | 9 | 78 | |
Histological type | |||
A-B2 | 52 | 98 | 0.074 |
B3 | 8 | 86 | |
Myasthenia gravis | |||
present | 11 | 100 | 0.478 |
absent | 49 | 96 | |
Resection status | |||
Complete resection | 53 | 100 | < 0.001 |
Incomplete resection | 7 | 71 | |
Recurrent-free interval (years) | |||
< 3 | 6 | 83 | 0.307 |
≧3 | 2 | 100 |